LAS VEGAS, Nov. 12, 2014 /PRNewswire/ -- RAMOIL
MANAGEMENT, Ltd (OTCPink: RAMO) wants to honor and support our
veterans by announcing that RAMO Bio-Med, Inc., its wholly owned
subsidiary, is beginning with controlled clinical testing of "RAMO
CBD" and "RAMO THC" formulas for the treatment of Post Traumatic
Stress Disorder, commonly known as PTSD.
Said testing will be conducted with and through established
clinics, specialized in Pain Management and the treatment of
PTSD. Presently, we have confirmation of participation in
Southern California and are in
discussions with another clinic in Florida to conduct this product testing.
Michael Goeree, Ramoil
Management's Chairman, President and Chief Executive Officer,
said: "We are proud to be beginning to work with PTSD
Patients and are opening talks with a leading national PTSD
organization in the hope of making a difference in our veteran's
lives by offering them discounts on medicines and even a proposed
assistance program."
Dwight Chornomud, Natural
Elements Group's President and CEO said: "We too are more
than happy to be assisting Ramoil Management and RAMO Bio-Med in
this worth while clinical testing."
About Ramoil Management, Ltd.
Ramoil Management, Ltd.
(RAMO) is a development stage company. The Company is an
online wholesaler of E-cigarettes containing nutraceutical vapor
oils, E-cigarette delivery systems and hydroponic lighting and
nutrients. Through its wholly owned subsidiary, RAMO Bio-Med,
Inc., it is operating a "Supercritical CO2 Molecular Extraction"
system and is planning to build production facilities and research
labs, both domestically and internationally, focused on its own
proprietary strain of high CBD – extremely low THC Extraction
Facilities (Labs and Manufacturing), for the development,
production and sales of CBD extractions, concentrates and
medicines.
About Natural Elements Group, Inc.
Natural Elements
Group, Inc. is an established California Mutual Benefit Non-Profit
Medical Marijuana Collective. Natural Elements Group, Inc.
presently operates as a multiple member medical marijuana
collective, dispensary and distribution company, with production
facilities in both Southern and Northern
California.
Forward Looking Statements:
This news release contains forward-looking statements made by
RAMOIL MANAGEMENT, LTD. All such statements included in this press
release, other than statements of historical fact, are
forward-looking statements. Although management believes that
the expectations reflected in such forward-looking statements are
reasonable, it can give no assurance that such expectations will
prove to have been correct. Actual results may differ materially
from those indicated by these statements. The following risk
factors, among others, could cause actual results to differ
materially from those described in any forward-looking statements.
These risks and uncertainties include, but are not limited to,
economic conditions, changes in the law or regulations, demand for
products of the Company, the effects of competition and other
factors that could cause actual results to differ materially from
those projected or represented in the forward looking statements.
Forward-looking statements are typically identified by the words:
believe, expect, anticipate, intend, estimate, and similar
expressions or which by their nature refer to future events.
The Company is not entitled to rely on the safe harbor provisions
of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934 because it is not registered under
either Act.
Company and Investor Relations Contact:
Frank Blainey, Esq. at:
+1-702-381-1961
Ramoilir@gmail.com
SOURCE Ramoil Management, Ltd.